Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockers (Q33913921)

30 July 2017

1 reference

title

Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockers (English)

1 reference

30 July 2017

1 reference

7

Häring HU

1 reference

30 July 2017

Jacob S

1

1 reference

30 July 2017

Balletshofer B

2

1 reference

30 July 2017

Henriksen EJ

3

1 reference

30 July 2017

Volk A

4

1 reference

30 July 2017

Mehnert B

5

1 reference

30 July 2017

Löblein K

6

1 reference

30 July 2017

Rett K

8

1 reference

30 July 2017

publication date

1 January 1999

1 reference

30 July 2017

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

5-6

1 reference

30 July 2017

page(s)

261-268

1 reference

Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Role of insulin resistance in human disease (syndrome X): an expanded definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Cardiovascular risk factors in treated hypertensives--a nation-wide, cross-sectional study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Metabolic considerations in the choice of therapy for the patient with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Hyperinsulinemia Is Associated With the Incidence of Hypertension and Dyslipidemia in Middle-Aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Do antihypertensive drugs precipitate diabetes in predisposed men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Long term propranolol treatment and changes in body weight after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Metabolic effects of carvedilol in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/080370599439463

21 January 2018

Identifiers

DOI

10.1080/080370599439463

1 reference

30 July 2017

1 reference